| 1 | Autoimmune encephalomyelitis in <scp>NOD</scp> mice is not initially a progressive multiple sclerosis model | 3.9 | 22 | Citations (PDF) |
| 2 | Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) | 3.4 | 917 | Citations (PDF) |
| 3 | Metabolomics and Lipidomics Study of Mouse Models of Type 1 Diabetes Highlights Divergent Metabolism in Purine and Tryptophan Metabolism Prior to Disease Onset | 3.7 | 50 | Citations (PDF) |
| 4 | Failure of the Anti-Inflammatory Parasitic Worm Product ES-62 to Provide Protection in Mouse Models of Type I Diabetes, Multiple Sclerosis, and Inflammatory Bowel Disease | 4.4 | 16 | Citations (PDF) |
| 5 | Non-Invasive Multiphoton Imaging of Islets Transplanted Into the Pinna of the NOD Mouse Ear Reveals the Immediate Effect of Anti-CD3 Treatment in Autoimmune Diabetes | 5.0 | 10 | Citations (PDF) |
| 6 | Immunosuppression overcomes insulin- and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice | 3.7 | 9 | Citations (PDF) |
| 7 | Anti‐<scp>CD</scp>3 treatment up‐regulates programmed cell death protein‐1 expression on activated effector T cells and severely impairs their inflammatory capacity | 4.8 | 36 | Citations (PDF) |
| 8 | Neuroendrocrine effects on autoimmunity | 38.9 | 0 | Citations (PDF) |
| 9 | Guidelines for the use of flow cytometry and cell sorting in immunological studies<sup>*</sup> | 3.4 | 564 | Citations (PDF) |
| 10 | Hyperglycaemia does not affect antigen-specific activation and cytolytic killing by CD8+ T cells <i>in vivo</i> | 3.9 | 11 | Citations (PDF) |
| 11 | Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environment | 2.5 | 16 | Citations (PDF) |
| 12 | A SNP in the Immunoregulatory Molecule CTLA-4 Controls mRNA Splicing In Vivo but Does Not Alter Diabetes Susceptibility in the NOD Mouse | 0.5 | 6 | Citations (PDF) |
| 13 | Opposing effects on the cell cycle of T lymphocytes by Fbxo7 via Cdk6 and p27 | 5.6 | 19 | Citations (PDF) |
| 14 | Inhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine Production | 2.5 | 4 | Citations (PDF) |
| 15 | The Schistosoma mansoni T2 ribonuclease omega-1 modulates inflammasome-dependent IL-1β secretion in macrophages | 3.0 | 39 | Citations (PDF) |
| 16 | Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice | 2.9 | 4 | Citations (PDF) |
| 17 | Helminth mediated modulation of Type 1 diabetes (T1D) | 3.0 | 25 | Citations (PDF) |
| 18 | Immune mechanisms in type 1 diabetes | 9.1 | 135 | Citations (PDF) |
| 19 | Regulation unmasked by activation | 24.9 | 2 | Citations (PDF) |
| 20 | Type 1 diabetes: translating mechanistic observations into effective clinical outcomes | 38.9 | 216 | Citations (PDF) |
| 21 | Vaccine against autoimmune disease: can helminths or their products provide a therapy? | 5.6 | 33 | Citations (PDF) |
| 22 | Accelerated Turnover of MHC Class II Molecules in Nonobese Diabetic Mice Is Developmentally and Environmentally Regulated In Vivo and Dispensable for Autoimmunity | 0.6 | 12 | Citations (PDF) |
| 23 | Butyrophilin Btn2a2 Inhibits TCR Activation and Phosphatidylinositol 3-Kinase/Akt Pathway Signaling and Induces Foxp3 Expression in T Lymphocytes | 0.6 | 42 | Citations (PDF) |
| 24 | The Nonconventional MHC Class II Molecule DM Governs Diabetes Susceptibility in NOD Mice | 2.5 | 21 | Citations (PDF) |
| 25 | Inflammation and type one diabetes | 3.5 | 57 | Citations (PDF) |
| 26 | Parasitic worms and inflammatory disease | 4.2 | 15 | Citations (PDF) |
| 27 | Factors Involved in Onset of Type 1 Diabetes | 0.0 | 0 | Citations (PDF) |
| 28 | The 1st International standard for transforming growth factor-β3 (TGF-β3) | 1.5 | 1 | Citations (PDF) |
| 29 | Genetic Analysis of Type 1 Diabetes: Embryonic Stem Cells as New Tools to Unlock Biological Mechanisms in Type 1 Diabetes | 2.9 | 2 | Citations (PDF) |
| 30 | CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes | 5.6 | 74 | Citations (PDF) |
| 31 | Infectious triggers protect from autoimmunity | 6.6 | 15 | Citations (PDF) |
| 32 | Autoimmunity and inflammation: murine models and translational studies | 2.5 | 19 | Citations (PDF) |
| 33 | The <i>S. mansoni</i> glycoprotein ω‐1 induces Foxp3 expression in NOD mouse CD4<sup>+</sup> T cells | 3.4 | 89 | Citations (PDF) |
| 34 | PD‐L1 blockade overrides <i>Salmonella typhimurium</i>‐mediated diabetes prevention in NOD mice: No role for Tregs | 3.4 | 12 | Citations (PDF) |
| 35 | Epigenetic Changes at <i>Il12rb2</i> and <i>Tbx21</i> in Relation to Plasticity Behavior of Th17 Cells | 0.6 | 62 | Citations (PDF) |
| 36 | OdDHL Inhibits T Cell Subset Differentiation and Delays Diabetes Onset in NOD Mice | 3.2 | 6 | Citations (PDF) |
| 37 | Importance of TLR2 in the direct response of T lymphocytes to <i>Schistosoma mansoni</i> antigens | 3.4 | 22 | Citations (PDF) |
| 38 | Harnessing CD8+ Regulatory T Cells: Therapy for Type 1 Diabetes? | 16.7 | 7 | Citations (PDF) |
| 39 | Immune cell crosstalk in type 1 diabetes | 38.9 | 442 | Citations (PDF) |
| 40 | Immune Modulation by<i>Schistosoma mansoni</i>Antigens in NOD Mice: Effects on Both Innate and Adaptive Immune Systems | 2.4 | 92 | Citations (PDF) |
| 41 | Roles for TGF-β and Programmed Cell Death 1 Ligand 1 in Regulatory T Cell Expansion and Diabetes Suppression by Zymosan in Nonobese Diabetic Mice | 0.6 | 26 | Citations (PDF) |
| 42 | <i>Schistosoma mansoni</i> egg antigens induce Treg that participate in diabetes prevention in NOD mice | 3.4 | 178 | Citations (PDF) |
| 43 | Review series on helminths, immune modulation and the hygiene hypothesis: How might infection modulate the onset of type 1 diabetes? | 4.8 | 82 | Citations (PDF) |
| 44 | Validated germline-competent embryonic stem cell lines from nonobese diabetic mice | 36.5 | 195 | Citations (PDF) |
| 45 | Overcoming self-destruction in the pancreas | 7.6 | 9 | Citations (PDF) |
| 46 | Infection and autoimmunity | 1.5 | 31 | Citations (PDF) |
| 47 | 17-P013 Consequences and applications of suppression of Erk signalling in early mouse embryos | 1.6 | 0 | Citations (PDF) |
| 48 | Can infections protect against autoimmunity? | 4.2 | 15 | Citations (PDF) |
| 49 | Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice | 9.1 | 494 | Citations (PDF) |
| 50 | Type 1 Diabetes Development Requires Both CD4+ and CD8+ T cells and Can Be Reversed by Non-Depleting Antibodies Targeting Both T Cell Populations | 2.9 | 96 | Citations (PDF) |
| 51 | The hygiene hypothesis and Type 1 diabetes 2009, , 179-188 | | 1 | Citations (PDF) |
| 52 | Interplay of parasite-driven immune responses and autoimmunity | 3.3 | 56 | Citations (PDF) |
| 53 | Death in the AIRE | 9.1 | 17 | Citations (PDF) |
| 54 | Both central and peripheral tolerance mechanisms play roles in diabetes prevention in NOD-E transgenic mice | 3.1 | 11 | Citations (PDF) |
| 55 | Comment on: Tritt et al. (2007) Functional Waning of Naturally Occurring CD4+ Regulatory T-cells Contributes to the Onset of Autoimmune Diabetes: <i>Diabetes</i> 57:113–123, 2007 | 0.5 | 3 | Citations (PDF) |
| 56 | AIRE's CARD Revealed, a New Structure for Central Tolerance Provokes Transcriptional Plasticity | 2.3 | 89 | Citations (PDF) |
| 57 | Immune-Potentiating Effects of the Chemotherapeutic Drug Cyclophosphamide | 0.6 | 152 | Citations (PDF) |
| 58 | Inhibition of Autoimmune Type 1 Diabetes by Gastrointestinal Helminth Infection | 2.8 | 219 | Citations (PDF) |
| 59 | Patients With Chronic Pancreatitis Have Islet Progenitor Cells in Their Ducts, but Reversal of Overt Diabetes in NOD Mice by Anti-CD3 Shows No Evidence for Islet Regeneration | 0.5 | 51 | Citations (PDF) |
| 60 | Murine Gammaherpesvirus-68 Infection Alters Self-Antigen Presentation and Type 1 Diabetes Onset in NOD Mice | 0.6 | 47 | Citations (PDF) |
| 61 | Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+regulatory T cells | 4.8 | 90 | Citations (PDF) |
| 62 | An early age-related increase in the frequency of CD4+ Foxp3+cells in BDC2·5NOD mice | 4.8 | 37 | Citations (PDF) |
| 63 | <i>Salmonella typhimurium</i> Infection in Nonobese Diabetic Mice Generates Immunomodulatory Dendritic Cells Able to Prevent Type 1 Diabetes | 0.6 | 56 | Citations (PDF) |
| 64 | Cyclophosphamide-Induced Type-1 Diabetes in the NOD Mouse Is Associated with a Reduction of CD4+CD25+Foxp3+ Regulatory T Cells | 0.6 | 180 | Citations (PDF) |
| 65 | Loss of Invariant Chain Protects Nonobese Diabetic Mice against Type 1 Diabetes | 0.6 | 14 | Citations (PDF) |
| 66 | Th17 Cells in Inflammatory Conditions | 2.9 | 65 | Citations (PDF) |
| 67 | MAdCAM-1 is needed for diabetes development mediated by the T cell clone, BDC-2.5 | 4.8 | 20 | Citations (PDF) |
| 68 | A worm's eye view of the immune system: consequences for evolution of human autoimmune disease | 38.9 | 218 | Citations (PDF) |
| 69 | Characterisation of CD8 monoclonal antibody-induced protection from diabetes in NOD mice | 3.1 | 3 | Citations (PDF) |
| 70 | Genetic Diversity in NK and NKT Cells 2005, , 110-117 | | 0 | Citations (PDF) |
| 71 | Different Diabetogenic Potential of Autoaggressive CD8+ Clones Associated with IFN-γ-Inducible Protein 10 (CXC Chemokine Ligand 10) Production but Not Cytokine Expression, Cytolytic Activity, or Homing Characteristics | 0.6 | 31 | Citations (PDF) |
| 72 | IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse | 2.9 | 40 | Citations (PDF) |
| 73 | The Role of Regulatory T Cell Defects in Type I Diabetes and the Potential of these Cells for Therapy | 2.9 | 24 | Citations (PDF) |
| 74 | Infection and autoimmunity: are we winning the war, only to lose the peace? | 3.3 | 91 | Citations (PDF) |
| 75 | Autoimmunity | 5.6 | 3 | Citations (PDF) |
| 76 | Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice | 3.4 | 44 | Citations (PDF) |
| 77 | Non-depleting Anti-CD4 Antibody not only Prevents Onset but Resolves Sialadenitis in NOD Mice | 3.1 | 8 | Citations (PDF) |
| 78 | Mechanisms of autoimmune thyroid disease | 0.6 | 3 | Citations (PDF) |
| 79 | The Impact of Infection on the Incidence of Autoimmune Disease | 2.7 | 12 | Citations (PDF) |
| 80 | <i>Schistosoma mansoni</i> antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes | 3.4 | 312 | Citations (PDF) |
| 81 | Tumour necrosis factor-alpha is a fundamental cytokine in autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide in interleukin-12 p40 deficient C57BL/6 mice | 4.8 | 16 | Citations (PDF) |
| 82 | An islet-homing NOD CD8+cytotoxic T cell clone recognizes GAD65and causes insulitis | 6.8 | 23 | Citations (PDF) |
| 83 | Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice1 | 0.8 | 26 | Citations (PDF) |
| 84 | Cross-reactive Mycobacterial and Self hsp60 Epitope Recognition in I-Ag7 Expressing NOD, NOD-asp and Biozzi AB/H Mice | 6.8 | 8 | Citations (PDF) |
| 85 | Perturbation of naive TCR transgenic T cell functional responses and upstream activation events by anti-CD4 monoclonal antibodies | 3.4 | 21 | Citations (PDF) |
| 86 | Autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide is inhibited by soluble TNF receptor type I | 3.4 | 24 | Citations (PDF) |
| 87 | Beneficial Effects of Non-Depleting Anti-CD4 in MRL/Mp-
<i>lpr/lpr</i>
Mice with Active Systemic Lupus Erythematosus and Microscopic Angiitis | 3.1 | 7 | Citations (PDF) |
| 88 | Tolerogenic strategies to halt or prevent type 1 diabetes | 24.9 | 45 | Citations (PDF) |
| 89 | Cutting Edge: Interactions Through the IL-10 Receptor Regulate Autoimmune Diabetes | 0.6 | 42 | Citations (PDF) |
| 90 | Role of MHC class I expression and CD8+ T cells in the evolution of iodine-induced thyroiditis in NOD-H2h4 and NOD mice | 3.4 | 43 | Citations (PDF) |
| 91 | Nondepleting Anti-CD4 Has an Immediate Action on Diabetogenic Effector Cells, Halting Their Destruction of Pancreatic β Cells | 0.6 | 37 | Citations (PDF) |
| 92 | T Cell Reactivity to Heat Shock Protein 60 in Diabetes-Susceptible and Genetically Protected Nonobese Diabetic Mice Is Associated with a Protective Cytokine Profile | 0.6 | 17 | Citations (PDF) |
| 93 | Triggering a Second T Cell Receptor on Diabetogenic T Cells Can Prevent Induction of Diabetes | 8.1 | 25 | Citations (PDF) |
| 94 | Factors Involved in the Pathogenesis of Neutrophilic Vasculitis in MRL/Mp-lpr/lprMice: A Model for Human Microscopic Angiitis | 3.1 | 6 | Citations (PDF) |
| 95 | Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice | 2.1 | 318 | Citations (PDF) |
| 96 | Both CD4+T Cells and CD8+T Cells Are Required for Iodine Accelerated Thyroiditis in NOD Mice | 2.6 | 77 | Citations (PDF) |
| 97 | Generation and maintenance of autoantigen-specific CD8+ T cell clones isolated from NOD mice | 1.5 | 13 | Citations (PDF) |
| 98 | The involvement of IL-12 in murine experimentally induced autoimmune thyroid disease | 3.4 | 40 | Citations (PDF) |
| 99 | Myeloperoxidase autoantibodies distinguish vasculitis mediated by anti-neutrophil cytoplasm antibodies from immune complex disease in MRL/Mp-lpr/lprmice: a spontaneous model for human microscopic angiitis | 3.4 | 48 | Citations (PDF) |
| 100 | Thymus-dependent monoclonal antibody-induced protection from transferred diabetes | 3.4 | 13 | Citations (PDF) |
| 101 | Syngeneic Islet Transplantation in Prediabetic BB-DP Rats - A Synchronized Model for Studying, βCell Destruction during the Development of IDDM | 3.1 | 11 | Citations (PDF) |
| 102 | Protection from Insulin Dependent Diabetes Mellitus Afforded by Insulin Antigens in Incomplete Freund's Adjuvant Depends on Route of Administration | 6.8 | 38 | Citations (PDF) |
| 103 | Development of a procedure for the direct cloning of T-cell epitopes using bacterial expression systems | 1.5 | 7 | Citations (PDF) |
| 104 | Unique role of thyroxine in T cell recognition of a pathogenic peptide in experimental autoimmune thyroiditis | 3.4 | 19 | Citations (PDF) |
| 105 | Experimental models of autoimmune thyroid disease 1996, , 1775-1785 | | 0 | Citations (PDF) |
| 106 | The Effect of MHC Encoding Transgenes on IDDM in NOD Mice 1996, , 82-88 | | 0 | Citations (PDF) |
| 107 | Tolerance Induction as a Therapeutic Strategy for the Control of Autoimmune Endocrine Disease in Mouse Models | 6.8 | 30 | Citations (PDF) |
| 108 | The genetics of the NOD mouse | 0.6 | 23 | Citations (PDF) |
| 109 | The role of infiltrating macrophages in islet destruction and regrowth in a transgenic model | 6.8 | 7 | Citations (PDF) |
| 110 | Animal models of autoimmune endocrine disease and their uses in developing new methods of intervention | 0.8 | 0 | Citations (PDF) |
| 111 | Autoimmune Disease: Gadding around the beta cell | 4.0 | 4 | Citations (PDF) |
| 112 | Peptide therapy for diabetes | 14.8 | 13 | Citations (PDF) |
| 113 | Effect of MHC Class II Encoding Transgenes on Autoimmunity in Nonobese Diabetic Mice 1994, , 183-190 | | 0 | Citations (PDF) |
| 114 | Active suppression induced by anti-CD4 | 3.4 | 39 | Citations (PDF) |
| 115 | The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes | 3.4 | 43 | Citations (PDF) |
| 116 | Immunotherapy of autoimmune disease | 5.6 | 14 | Citations (PDF) |
| 117 | Complete characterization of the expressed immune response genes in Biozzi AB/H mice: structural and functional identity between AB/H and NOD A region molecules | 2.8 | 34 | Citations (PDF) |
| 118 | Autoantigens in thyroid diseases | 3.4 | 21 | Citations (PDF) |
| 119 | Prevention of Diabetes but not Insulitis in NOD Mice Injected with Antibody to CD4 | 6.8 | 28 | Citations (PDF) |
| 120 | The Regulation of Autoimmunity Through CD4+ T Cells | 3.1 | 13 | Citations (PDF) |
| 121 | The forces driving autoimmune disease | 6.8 | 35 | Citations (PDF) |
| 122 | Breast may well be best | 34.3 | 3 | Citations (PDF) |
| 123 | Thyroid autoimmunity | 5.6 | 19 | Citations (PDF) |
| 124 | Altered course of visceral leishmaniasis in mice expressing transgenic I-E molecules | 3.4 | 40 | Citations (PDF) |
| 125 | The use of a non-depleting anti-CD4 monoclonal antibody to re-establish tolerance to β cells in NOD mice | 3.4 | 112 | Citations (PDF) |
| 126 | Expression of major histocompatibility complex class I antigens at low levels in the thymus induces T cell tolerance via a non-deletional mechanism | 3.4 | 34 | Citations (PDF) |
| 127 | The development of insulin-dependent diabetes mellitus in non-obese diabetic mice: the role of CD4+ and CD8+ T cells | 4.2 | 14 | Citations (PDF) |
| 128 | Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression | 3.4 | 129 | Citations (PDF) |
| 129 | Expression and function of Qa-2 major histocompatibility complex class I molecules in transgenic mice | 3.5 | 15 | Citations (PDF) |
| 130 | Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain | 34.3 | 346 | Citations (PDF) |
| 131 | Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages | 34.3 | 242 | Citations (PDF) |
| 132 | Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis | 3.4 | 72 | Citations (PDF) |
| 133 | The involvement of Ly 2+ T cells in beta cell destruction | 6.8 | 46 | Citations (PDF) |
| 134 | Restriction fragment length polymorphisms in the major histocompatibility complex of the non-obese diabetic mouse | 6.8 | 11 | Citations (PDF) |
| 135 | The detection and enumeration of cytokine-secreting cells in mice and man and the clinical application of these assays | 1.5 | 64 | Citations (PDF) |
| 136 | The Role of Antigen in Autoimmune Responses with Special Reference to Changes in Carbohydrate Structure of IgG in Rheumatoid Arthritis 1989, , 3-10 | | 1 | Citations (PDF) |
| 137 | Phenotypic characteristics of cells involved in induced suppression to murine experimental autoimmune thyroiditis | 3.4 | 40 | Citations (PDF) |
| 138 | The role of antigen in autoimmune responses with special reference to changes in carbohydrate structure of IgG in rheumatoid arthritis | 6.8 | 20 | Citations (PDF) |
| 139 | Idiotypic interactions in autoimmunity: an editorial overview | 6.8 | 4 | Citations (PDF) |
| 140 | Current Molecular Approaches to Experimental Thyroid Autoimmunity | 0.0 | 4 | Citations (PDF) |
| 141 | The nature of autoantigens | 1.5 | 0 | Citations (PDF) |
| 142 | The role of autoantigen in autoimmunity | 2.4 | 12 | Citations (PDF) |
| 143 | High efficiency antigen presentation by thyroglobulinprimed murine splenic B cells | 3.4 | 40 | Citations (PDF) |
| 144 | Cytotoxicity of tumor necrosis factor for thyroid epithelial cells and its regulation by interferon-γ | 3.4 | 46 | Citations (PDF) |
| 145 | CD5-positive B cells in rheumatoid arthritis and chronic lymphocytic leukemia | 7.1 | 74 | Citations (PDF) |
| 146 | Natural autoantibodies might prevent autoimmune disease | 7.1 | 140 | Citations (PDF) |
| 147 | Autoimmune disorders | 7.1 | 4 | Citations (PDF) |
| 148 | AUTOIMMUNITY AND IDIOTYPES | 14.8 | 43 | Citations (PDF) |
| 149 | The differential effect of 2-deoxyguanosine on concanavalin A-induced suppressor and cytotoxic activity | 2.6 | 3 | Citations (PDF) |
| 150 | Idiotypes and autoimmunity | 3.4 | 41 | Citations (PDF) |
| 151 | Mechanisms of autoimmunity: a role for cross-reactive idiotypes | 7.1 | 61 | Citations (PDF) |
| 152 | Differential sensitivity to 2′-deoxyguanosine of antigen-specific and nonspecific suppressor T cells in delayed hypersensitivity | 2.6 | 6 | Citations (PDF) |
| 153 | Independent segregation of NZB immune abnormalities in NZB X C58 recombinant inbred mice | 3.4 | 53 | Citations (PDF) |
| 154 | Action of Con A-induced suppressor cells on a B hybridoma line | 2.6 | 0 | Citations (PDF) |
| 155 | The Role of T Cells in Autoimmune Diseases | 3.0 | 10 | Citations (PDF) |
| 156 | EFFECT OF CYCLOSPORIN A ON THE FUNCTION OF T CELLS | 0.8 | 11 | Citations (PDF) |
| 157 | Deficient production of anti-red cell autoantibodies by mice with an X-linked B lymphocyte defect | 3.4 | 22 | Citations (PDF) |
| 158 | Con-A-induced suppressor activity of lymphocytes distinguished by the presence or absence of the Fc receptor | 2.6 | 4 | Citations (PDF) |
| 159 | Evidence that intracellular and secreted light chains of a mouse IgG2a plasmacytoma are monomers carrying a free thiol group | 1.3 | 1 | Citations (PDF) |
| 160 | In vitro conversion of normal mouse lymphocytes by plasmacytoma RNA to express idiotypic specificities on their surface characteristic of the plasmacytoma immunoglobulin | 2.6 | 39 | Citations (PDF) |
| 161 | Stimulation of the activities of solubilized pig lymphocyte RNA polymerases by phytohaemagglutinin | 2.1 | 13 | Citations (PDF) |
| 162 | Effect of phytohaemagglutinin on the nuclear RNA polymerase activity of human lymphocytes | 3.2 | 16 | Citations (PDF) |
| 163 | Antibody of Restricted Heterogeneity secreted by Spleen Fragments | 4.6 | 3 | Citations (PDF) |
| 164 | Ornithine decarboxylase in phytohaemagglutinin stimulated lymphocytes: Control of degradation rate by amino acids | 2.8 | 26 | Citations (PDF) |
| 165 | Ornithine decarboxylase and ribosomal RNA synthesis during the stimulation of lymphocytes by phytohaemagglutinin | 2.8 | 44 | Citations (PDF) |
